References
- Linn FH, Rinkel GJ, Algra A, van Gijn J. Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke 1996;27:625–9.
- van Gijn J, Rinkel GJ. Subarachnoid haemorrhage: diagnosis, causes and management. Brain 2001;124:249–78.
- Fujii Y, Takeuchi S, Sasaki O, Ultra-early rebleeding in spontaneous subarachnoid hemorrhage. J Neurosurg 1996;84:35–42.
- Kassell NF, Torner JC. Aneurysmal rebleeding: a preliminary report from the Cooperative Aneurysm Study. Neurosurgery 1983;13:479–81.
- Espina IM, Varon J. Clevidipine: a state-of-the-art antihypertensive drug under the scope. Expert Opin Pharmacother 2012;13:387–93.
- Meyer T, Tobias JD. Perioperative blood pressure management with clevidipine during coiling of cerebral artery aneurysms. Saudi J Anaesth 2009;3:83–6.
- Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968;28:14–20.
- Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974;2:81–4.
- Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980;6:1–9.
- Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991;54:1044–54.
- Pollack CV, Varon J, Garrison NA, Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension. Ann Emerg Med 2009;53:329–38.
- Ohkuma H, Tsurutani H, Suzuki S. Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management. Stroke 2001;32:1176–80.
- Naidech AM, Janjua N, Kreiter KT, Predictors and impact of aneurysm rebleeding after subarachnoid hemorrhage. Arch Neurol 2005;62:410–6.
- Wijdicks EF, Vermeulen M, Murray GD, The effects of treating hypertension following aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg 1990;92:111–7.
- Mayberg MR, Batjer HH, Dacey R, Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994;25:2315–28.
- Levy JH, Mancao MY, Gitter R, Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: the results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1. Anesth Analg 2007;105:918–25.
- Singla N, Warltier DC, Gandhi SD, Treatment of acute postoperative hypertension in cardiac surgery patients: an efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized, double-blind, placebo-controlled trial. Anesth Analg 2008;107:59–67.
- Graffagnino C, Bergese S, Love J, Aggressive blood pressure control with clevidipine in patients with acute intracerebral hemorrhage is rapid and well tolerated: the ACCELERATE trial. Stroke 2011;42:e218.
- Varelas PN, Abdelhak T, Wellwood J, Nicardipine infusion for blood pressure control in patients with subarachnoid hemorrhage. Neurocrit Care 2010;13:190–8.
- Aronson S, Dyke CM, Stierer KA, The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. Anesth Analg 2008;107: 1110–21.
- Ericsson H, Fakt C, Hoglund L, Pharmacokinetics and pharmacodynamics of clevidipine in healthy volunteers after intravenous infusion. Eur J Clin Pharmacol 1999;55:61–7.
- Halpern NA, Alicea M, Krakoff LR, Greenstein R. Postoperative hypertension: a prospective, placebo-controlled, randomized, double-blind trial, with intravenous nicardipine hydrochloride. Angiology 1990;41:992–1004.